Our Biotts team – Dr. Paweł Biernat, CEO & Transdermal Systems Specialist, and Jan Hendriks, CBO, took part in the annual conference Advanced Technologies & Treatments for Diabetes (ATTD) 2023 in Berlin. The event brought together developers of new technologies with distinguished diabetes professionals and caretakers, researchers, industries, startup companies, investors, reimbursement authorities and regulators, as well as people with diabetes. The purpose of the ATTD meeting was to highlight innovative technologies and treatments in diabetes management.
The presence at ATTD was a great opportunity for our representatives to discuss with international experts the use of groundbreaking transdermal carriers in the treatment of diabetes and support for patients with chronic diseases.
The opportunity to attend this year’s ATTD is the result of our victory in a competition that was held at the 5th Forum of Modern Diabetology in December of last year. Thanks again to the organizers of that event for recognizing our work!